DOCSLIB.ORG

What Drugs Are Effective for Periodic Limb Movement Disorder?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
What Drugs Are Effective for Periodic Limb Movement Disorder? Evidence-based answers from the clinical inquiries Family Physicians Inquiries Network Yuri A. Lee, MD; Philip Huynh, PharmD; Jon O. Neher, MD What drugs are effective Valley Family Medicine, Renton, Wash for periodic limb Sarah Safranek, MLIS University of Washington Health Sciences movement disorder? Library, Seattle EvidEncE-basEd answEr ASSISTANT EDITOR Gary Kelsberg, MD Valley Family Medicine, clonazepam improves subjective effect on subjective sleep quality varies; Renton, Wash A sleep quality and polysomnogram valproate improves only subjective mea- (PSG) measures of leg movements more sures; apomorphine injections reduce limb than placebo (strength of recommendation movements but not awakenings (SOR: C, [SOR]: B, a small randomized controlled very small crossover and cohort trials). trial [RCT]); temazepam produces similar Estrogen replacement therapy is inef- results (SOR: C, extrapolated from a small fective for periodic limb movement disor- comparison trial). der (PLMD) associated with menopause Melatonin and L-dopa consistently (SOR: B, RCT). improve certain PSG measures, but their Evidence summary mazepam and clonazepam appeared to be Although PLMD often occurs in association comparably effective; the trial was under- with restless legs syndrome, sleep apnea, nar- powered to detect a difference between them. colepsy, and other sleep disorders, it is itself The CBT trial didn’t describe the fre- an intrinsic sleep disorder characterized by quency or duration of CBT clearly.3 It isn’t in- stereotyped limb movements and sleep dis- cluded in the TABLE. ruption.1 Most treatment studies of PLMD re- port both subjective and objective measures L-Dopa decreases leg motions, of sleep quality. Two commonly used objec- effects on subjective sleep symptoms vary tive measures, obtained by PSG, are the peri- Two comparison trials evaluated L-dopa odic leg movement (PLM) index and the PLM (combined with carbidopa). One trial com- arousal index. TheTABLE summarizes the evi- pared L-dopa with propoxyphene and place- dence of medication trials. bo, and the other compared it with pergolide, a bromocriptine agonist available in Canada Clonazepam improves subjective and Europe.4,5 sleep measures, leg movements In both trials, L-dopa consistently re- Three comparative trials evaluated clon- duced leg motions at night but produced a azepam against placebo, temazepam, and variable response in subjective sleep symp- cognitive behavioral therapy (CBT).1-3 In the toms and nocturnal waking. Propoxyphene placebo-controlled and temazepam trials, yielded modest improvements in subjec- clonazepam significantly improved subjec- tive sleep symptoms and nocturnal waking tive sleep parameters and leg movements.1,2 over placebo. The L-dopa–propoxyphene However, the studies produced conflicting comparison trial was underpowered to al- results as to whether clonazepam reduced low a statistical comparison between the awakening from limb movements. Both te- 2 medications. continuEd 296 ThE JourNal oF FamIly PracticE | may 2012 | Vol 61, No 5 TABLE How well do these medications work for periodic limb movement disorder? Improvement in Improvement in leg Improvement in waking subjective sleep movements: from leg movements: quality vs baseline, Plm index* vs baseline, Plm-arousal index† vs except where indicated Study design, medication except where indicated baseline, except where duration (N) (daily dose) (P value) (P value) indicated (P value) crossover, clonazepam Subject sleep score 26% vs placebo (<.05) 28% vs placebo (NS) placebo-controlled, (1 mg Po) (Self-assessment of 3 days Sleep and awakening (26)1 Quality Scale), 25% vs placebo (<.05) double-blind clonazepam Sleep maintenance: 34% (.025) 44% (.005) crossover, placebo- (1 mg Po) 37% (.025) controlled, 30 days (10)2 Temazepam Sleep maintenance: 26% (.05) 42% (.013) (30 mg Po) 67% (.005) double-blind, l-dopa Improved sleep 87% vs placebo 89% vs placebo (<.01) crossover, placebo- (100-200 mg Po) vs placebo: 6/6 patients (<.01) controlled, 42 days (6)4 Propoxyphene Improved sleep 35% vs placebo 57% vs placebo (<.05) (100-200 mg Po) vs placebo: (NS) 3/6 patients double-blind, l-dopa complete relief 45% (decrease in 56% (decrease in total crossover, (250 mg Po) of restlessness: nocturnal myoclonus nocturnal awakenings) 36 days 1/11 patients syndrome disturbed (NS) (11)5 cluster time) (<.025) Pergolide‡ complete relief 79% (decrease in 56% (decrease in total (0.125 mg Po) of restlessness: nocturnal myoclonus nocturnal awakenings) 9/11 patients syndrome disturbed (NS) cluster time) (<.001) cohort, melatonin resolved daytime 60% (.004) 59% (.031) 42 days (3 mg Po) sleepiness: (9)6 4/9 patients cohort, apomorphine Not reported 38% (<.05) 30% (NS) 3 days (0.5 mg (9)7 subcutaneous) cohort, Valproate Improved daytime 61% (NS) 62% (NS) 180 days (125-600 mg Po) alertness: (6)8 6/6 patients double-blind, Estrogen Not reported 0% vs placebo 23% vs placebo crossover, replacement (NS) (NS) placebo-controlled, therapy 210 days (71)9 (2.5 g estradiol gel or 50 µg estradiol patch) NS, not significant; Plm, periodic limb movement. *Plm Index=number of abnormal leg motions per hour. †Plm-arousal Index=number of awakenings from abnormal leg movements per hour of sleep. ‡Pergolide is available in canada and Europe, but not in the united States. continuEd jfpoNline.com Vol 61, No 5 | may 2012 | ThE JourNal oF FamIly PracticE 297 clinical inquiries Melatonin and valproate produce for PLMD enrolled postmenopausal wom- opposite effects in small studies en, about half of whom were found to have Three very small trials recorded symptoms and PLMD.9 The study found estrogen replace- PSG findings in patients taking melatonin, apo- ment therapy to be ineffective for treating morphine, or valproate, and compared them menopause-associated PLMD. with the values observed at baseline.6-8 Melato- nin significantly improved objective measures, but most patients didn’t feel less sleepy. Val- Recommendations proate produced the opposite effect—no clear Practice parameters developed by the Ameri- PSG improvements, but all study patients felt can Academy of Sleep Medicine state that better. Injected apomorphine reduced limb clonazepam, pergolide, L-dopa (with a de- movements but not awakenings. carboxylase inhibitor), oxycodone, and pro- poxyphene are all reasonable choices for Estrogen replacement therapy medical treatment of PLMD.10 The practice doesn’t help parameters don’t specify a preference for any An RCT of estrogen replacement therapy of these medications. JFP references 1. Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Restless legs syn- Sleep. 1993;16:717-723. drome (RLS) and periodic limb movement disorder (PLMD): 6. Kunz D, Bes F. Exogenous melatonin in periodic limb move- acute placebo-controlled sleep laboratory studies with clonaz- ment disorder: an open clinical trial and a hypothesis. Sleep. epam. Eur Neuropsychopharmacol. 2001;11:153-161. 2001;24:183-187. 2. Mitler MM, Browman CP, Menn SJ, et al. Nocturnal myoclo- 7. Haba-Rubio J, Staner L, Cornette F, et al. Acute low single dose nus: treatment efficacy of clonazepam and temazepam. Sleep. of apomorphine reduces periodic limb movements but has 1986;9:385-392. no significant effect on sleep arousals: a preliminary report. 3. Edinger JD, Fins AI, Sullivan RJ, et al. Comparison of cognitive- Neurophysiol Clin. 2003;33:180-184. behavioral therapy and clonazepam for treating periodic limb 8. Ehrenberg BL, Eisensehr I, Corbett KE, et al. Valproate for movement disorder. Sleep. 1996;19:442-444. sleep consolidation in periodic limb movement disorder. J Clin 4. Staedt J, Wassmuth F, Ziemann U, et al. Pergolide: treatment Psychopharmacol. 2000;20:574-578. of choice in restless legs syndrome (RLS) and nocturnal 9. Polo-Kantola P, Rauhala E, Erkkola R, et al. Estrogen replace- myoclonus syndrome (NMS). A double-blind randomized ment therapy and nocturnal periodic limb movements: a ran- crossover trial of pergolide versus L-Dopa. J Neural Transm. domized controlled trial. Obstet Gynecol. 2001;97:548-554. 1997;104:461-468. 10. Chesson AL Jr, Wise M, Davila D, et al. Practice parameters 5. Kaplan PW, Allen RP, Buchholz DW, et al. A double-blind, pla- for the treatment of restless legs syndrome and periodic limb cebo-controlled study of the treatment of periodic limb move- movement disorder. An American Academy of Sleep Medicine ments in sleep using carbidopa/levodopa and propoxyphene. Report. Sleep. 1999;22:961-968. SUPPLEMENT Health care models for treatment and management of diabetes Learn about alternative models for the treatment and management of patients with diabetes • Centralized multidisciplinary team approach • Medication therapy management services provided by pharmacists • Boutique medicine model Click on Supplements at jfponline.com or visit • Nurse practitioner-led approach http://www.jfponline.com/Pages.asp?id=10056 This supplement was sponsored by the Primary Care Metabolic Group and the Primary Care 298 ThE JourNal oF FamIly PracticE | may 2012 | Vol 61, No 5 Education Consortium and was supported by funding from Novo Nordisk, Inc..
Load more

Recommended publications
  • Spinal Segmental Myoclonus Masquerading As a Psychogenic Movement Disorder Laxmi Khanna1*, Anuradha Batra1 and Ankita Sharma2
    Short Communication iMedPub Journals Journal of Neurology and Neuroscience 2019 www.imedpub.com Vol.10 No.1:282 ISSN 2171-6625 DOI: 10.21767/2171-6625.1000282 Spinal Segmental Myoclonus Masquerading as a Psychogenic Movement Disorder Laxmi Khanna1*, Anuradha Batra1 and Ankita Sharma2 1Department of Neurology and Neurophysiology, Sir Gangaram Hospital, New Delhi, India 2Department of Neurophysiology, Sir Gangaram Hospital, New Delhi, India *Corresponding author: Dr. Laxmi Khanna, Consultant Neurologist and Neurophysiologist, Department of Neurology and Neurophysiology, Sir Gangaram Hospital, New Delhi–110060, India, Tel: 9873558121; E-mail: [email protected] Rec Date: December 26, 2018; Acc Date: January 05, 2019; Pub Date: January 11, 2019 Citation: Khanna L, Batra A, Sharma A (2019) Spinal Segmental Myoclonus Masquerading as a Psychogenic Movement Disorder. J Neurol Neurosci Vol.10 No.1:282. his lower back followed by a painless involuntary rhythmic forward jerking of his legs which lasted for thirty seconds Abstract (Figures 1 and 2). These attacks occurred at rest and before falling asleep. The jerks increased in frequency and intensity Spinal generated movement disorders are uncommon. An curtailing his social life. There was no past history of any elderly gentleman presented with distressing jerks of both trauma, myelitis, demyelination or infections with human lower limbs which caused him much social immunodeficiency virus. embarrassment. He had received psychiatric treatment for these abnormal muscular spasms without relief. He had become depressed and withdrawn when he first presented to our outpatient department. A routine clinical examination followed by a long-term video EEG with simultaneous EMG clinched the diagnosis of a spinal segmental myoclonus.
    [Show full text]
  • Clinical Controversies in Amyotrophic Lateral Sclerosis
    Clinical Controversies in Amyotrophic Lateral Sclerosis Authors: Ruaridh Cameron Smail,1,2 Neil Simon2 1. Department of Neurology and Neurophysiology, Royal North Shore Hospital, Sydney, Australia 2. Northern Clinical School, The University of Sydney, Sydney, Australia *Correspondence to [email protected] Disclosure: The authors have declared no conflicts of interest. Received: 26.02.20 Accepted: 28.04.20 Keywords: Amyotrophic lateral sclerosis (ALS), biomarker, clinical phenotype, diagnosis, motor neurone disease (MND), pathology, ultrasound. Citation: EMJ Neurol. 2020;8[1]:80-92. Abstract Amyotrophic lateral sclerosis is a devastating neurodegenerative condition with few effective treatments. Current research is gathering momentum into the underlying pathology of this condition and how components of these pathological mechanisms affect individuals differently, leading to the broad manifestations encountered in clinical practice. We are moving away from considering this condition as merely an anterior horn cell disorder into a framework of a multisystem neurodegenerative condition in which early cortical hyperexcitability is key. The deposition of TAR DNA-binding protein 43 is also a relevant finding given the overlap with frontotemporal dysfunction. New techniques have been developed to provide a more accurate diagnosis, earlier in the disease course. This goes beyond the traditional nerve conduction studies and needle electromyography, to cortical excitability studies using transcranial magnetic stimulation, and the use of ultrasound. These ancillary tests are proposed for consideration of future diagnostic paradigms. As we learn more about this disease, future treatments need to ensure efficacy, safety, and a suitable target population to improve outcomes for these patients. In this time of active research into this condition, this paper highlights some of the areas of controversy to induce discussion surrounding these topics.
    [Show full text]
  • Myoclonus Aspen Summer 2020
    Hallett Myoclonus Aspen Summer 2020 Myoclonus (Chapter 20) Aspen 2020 1 Myoclonus: Definition Quick muscle jerks Either irregular or rhythmic, but always simple 2 1 Hallett Myoclonus Aspen Summer 2020 Myoclonus • Spontaneous • Action myoclonus: activated or accentuated by voluntary movement • Reflex myoclonus: activated or accentuated by sensory stimulation 3 Myoclonus • Focal: involving only few adjacent muscles • Generalized: involving most or many of the muscles of the body • Multifocal: involving many muscles, but in different jerks 4 2 Hallett Myoclonus Aspen Summer 2020 Differential diagnosis of myoclonus • Simple tics • Some components of chorea • Tremor • Peripheral disorders – Fasciculation – Myokymia – Hemifacial spasm 9 Classification of Myoclonus Site of Origin • Cortex – Cortical myoclonus, epilepsia partialis continua, cortical tremor • Brainstem – Reticular myoclonus, exaggerated startle, palatal myoclonus • Spinal cord – Segmental, propriospinal • Peripheral – Rare, likely due to secondary CNS changes 10 3 Hallett Myoclonus Aspen Summer 2020 Classification of myoclonus to guide therapy • First consideration: Etiological classification – Is there a metabolic encephalopathy to be treated? Is there a tumor to be removed? Is a drug responsible? • Second consideration: Physiological classification – Can the myoclonus be treated symptomatically even if the underlying condition remains unchanged? 12 Myoclonus: Physiological Classification • Epileptic • Non‐epileptic The basic question to ask is whether the myoclonus is a “fragment
    [Show full text]
  • ASAH1 Variant Causing a Mild SMA Phenotype with No Myoclonic Epilepsy: a Clinical, Biochemical and Molecular Study
    European Journal of Human Genetics (2016) 24, 1578–1583 & 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 1018-4813/16 www.nature.com/ejhg ARTICLE ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study Massimiliano Filosto*,1, Massimo Aureli2, Barbara Castellotti3, Fabrizio Rinaldi1, Domitilla Schiumarini2, Manuela Valsecchi2, Susanna Lualdi4, Raffaella Mazzotti4, Viviana Pensato3, Silvia Rota1, Cinzia Gellera3, Mirella Filocamo4 and Alessandro Padovani1 ASAH1 gene encodes for acid ceramidase that is involved in the degradation of ceramide into sphingosine and free fatty acids within lysosomes. ASAH1 variants cause both the severe and early-onset Farber disease and rare cases of spinal muscular atrophy (SMA) with progressive myoclonic epilepsy (SMA-PME), phenotypically characterized by childhood onset of proximal muscle weakness and atrophy due to spinal motor neuron degeneration followed by occurrence of severe and intractable myoclonic seizures and death in the teenage years. We studied two subjects, a 30-year-old pregnant woman and her 17-year-old sister, affected with a very slowly progressive non-5q SMA since childhood. No history of seizures or myoclonus has been reported and EEG was unremarkable. The molecular study of ASAH1 gene showed the presence of the homozygote nucleotide variation c.124A4G (r.124a4g) that causes the amino acid substitution p.Thr42Ala. Biochemical evaluation of cultured fibroblasts showed both reduction in ceramidase activity and accumulation of ceramide compared with the normal control. This study describes for the first time the association between ASAH1 variants and an adult SMA phenotype with no myoclonic epilepsy nor death in early age, thus expanding the phenotypic spectrum of ASAH1-related SMA.
    [Show full text]
  • Restless Legs Syndrome and Periodic Limb Movements of Sleep
    Volume I, Issue 2 Restless Legs Syndrome and Periodic Limb Movements of Sleep Overview Periodic limb movement disorder (PLMD) ; May cause involuntary and restless leg syndrome (RLS) are jerking of the limbs distinct disorders, but often occur during sleep and simultaneously. Both PLMD and RLS are sometimes during also called (nocturnal) myoclonus, which wakefulness describes frequent or involuntary muscle spasms. Periodic limb movement was If you do have restless legs formally described first in the 1950s, and, syndrome (RLS), you are not alone. Up to Occupy your mind. Keeping your by the 1970s, it was listed as a potential 8% of the US population may have this mind actively engaged may lessen cause of insomnia. In addition to producing neurologic condition. Many people have a your symptoms of RLS. Find an similar symptoms, PLMD and RLS are mild form of the disorder, but RLS severely activity that you enjoy to help you treated similarly. affects the lives of millions of individuals. through those times when your symptoms are particularly What is Restless Legs Syndrome (RLS)? Living with RLS involves developing troublesome. Restless Legs Syndrome is an coping strategies that work for you. Here overwhelming urge to move the legs are some of our favorites. Rise to new levels. You may be more usually caused by uncomfortable or comfortable if you elevate your unpleasant sensations in the legs. It may Talk about RLS. Sharing information desktop or bookstand to a height that appear as a creepy crawly type of sensation about RLS will help your family will allow you to stand while you work or a tingling sensation.
    [Show full text]
  • Part Ii – Neurological Disorders
    Part ii – Neurological Disorders CHAPTER 14 MOVEMENT DISORDERS AND MOTOR NEURONE DISEASE Dr William P. Howlett 2012 Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania BRIC 2012 University of Bergen PO Box 7800 NO-5020 Bergen Norway NEUROLOGY IN AFRICA William Howlett Illustrations: Ellinor Moldeklev Hoff, Department of Photos and Drawings, UiB Cover: Tor Vegard Tobiassen Layout: Christian Bakke, Division of Communication, University of Bergen E JØM RKE IL T M 2 Printed by Bodoni, Bergen, Norway 4 9 1 9 6 Trykksak Copyright © 2012 William Howlett NEUROLOGY IN AFRICA is freely available to download at Bergen Open Research Archive (https://bora.uib.no) www.uib.no/cih/en/resources/neurology-in-africa ISBN 978-82-7453-085-0 Notice/Disclaimer This publication is intended to give accurate information with regard to the subject matter covered. However medical knowledge is constantly changing and information may alter. It is the responsibility of the practitioner to determine the best treatment for the patient and readers are therefore obliged to check and verify information contained within the book. This recommendation is most important with regard to drugs used, their dose, route and duration of administration, indications and contraindications and side effects. The author and the publisher waive any and all liability for damages, injury or death to persons or property incurred, directly or indirectly by this publication. CONTENTS MOVEMENT DISORDERS AND MOTOR NEURONE DISEASE 329 PARKINSON’S DISEASE (PD) � � � � � � � � � � �
    [Show full text]
  • The Serotonin Syndrome
    The new england journal of medicine review article current concepts The Serotonin Syndrome Edward W. Boyer, M.D., Ph.D., and Michael Shannon, M.D., M.P.H. From the Division of Medical Toxicology, he serotonin syndrome is a potentially life-threatening ad- Department of Emergency Medicine, verse drug reaction that results from therapeutic drug use, intentional self-poi- University of Massachusetts, Worcester t (E.W.B.); and the Program in Medical Tox- soning, or inadvertent interactions between drugs. Three features of the sero- icology, Division of Emergency Medicine, tonin syndrome are critical to an understanding of the disorder. First, the serotonin Children’s Hospital, Boston (E.W.B., M.S.). syndrome is not an idiopathic drug reaction; it is a predictable consequence of excess Address reprint requests to Dr. Boyer at IC Smith Bldg., Children’s Hospital, 300 serotonergic agonism of central nervous system (CNS) receptors and peripheral sero- 1,2 Longwood Ave., Boston, MA 02115, or at tonergic receptors. Second, excess serotonin produces a spectrum of clinical find- [email protected]. edu. ings.3 Third, clinical manifestations of the serotonin syndrome range from barely per- This article (10.1056/NEJMra041867) was ceptible to lethal. The death of an 18-year-old patient named Libby Zion in New York updated on October 21, 2009 at NEJM.org. City more than 20 years ago, which resulted from coadminstration of meperidine and phenelzine, remains the most widely recognized and dramatic example of this prevent- N Engl J Med 2005;352:1112-20. 4 Copyright © 2005 Massachusetts Medical Society. able condition.
    [Show full text]
  • The Clinical Approach to Movement Disorders Wilson F
    REVIEWS The clinical approach to movement disorders Wilson F. Abdo, Bart P. C. van de Warrenburg, David J. Burn, Niall P. Quinn and Bastiaan R. Bloem Abstract | Movement disorders are commonly encountered in the clinic. In this Review, aimed at trainees and general neurologists, we provide a practical step-by-step approach to help clinicians in their ‘pattern recognition’ of movement disorders, as part of a process that ultimately leads to the diagnosis. The key to success is establishing the phenomenology of the clinical syndrome, which is determined from the specific combination of the dominant movement disorder, other abnormal movements in patients presenting with a mixed movement disorder, and a set of associated neurological and non-neurological abnormalities. Definition of the clinical syndrome in this manner should, in turn, result in a differential diagnosis. Sometimes, simple pattern recognition will suffice and lead directly to the diagnosis, but often ancillary investigations, guided by the dominant movement disorder, are required. We illustrate this diagnostic process for the most common types of movement disorder, namely, akinetic –rigid syndromes and the various types of hyperkinetic disorders (myoclonus, chorea, tics, dystonia and tremor). Abdo, W. F. et al. Nat. Rev. Neurol. 6, 29–37 (2010); doi:10.1038/nrneurol.2009.196 1 Continuing Medical Education online 85 years. The prevalence of essential tremor—the most common form of tremor—is 4% in people aged over This activity has been planned and implemented in accordance 40 years, increasing to 14% in people over 65 years of with the Essential Areas and policies of the Accreditation Council age.2,3 The prevalence of tics in school-age children and for Continuing Medical Education through the joint sponsorship of 4 MedscapeCME and Nature Publishing Group.
    [Show full text]
  • Abnormal Movements in Sleep As a Post-Polio Sequelae
    Abnormal Movements in Sleep as a Post-Polio Sequelae AMERICAN JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 1998; 77: 1-6. Dr. Richard L. Bruno The Post-Polio Institute International Centre for Polio Education ABSTRACT Nearly two-thirds of polio survivors report abnormal movements in sleep (AMS), with 52% reporting that their sleep is disturbed by AMS. Sleep studies were performed in seven polio survivors to objectively document AMS. Two patients demonstrated Generalized Random Myoclonus (GRM), brief contractions and even ballistic movements of the arms and legs, slow repeated grasping movements of the hands, slow flexion of the arms and contraction of the shoulder and pectoral muscles. Two other patients demonstrated Periodic Movements in Sleep (PMS) with muscle contractions and ballistic movements of the legs, two had PMS plus Restless Leg Syndrome (RLS) and one had sleep starts involving only contraction of the arm muscles. AMS occurred in Stage II sleep in all patients, in Stage I in some, and could significantly disturb sleep architecture even though patients were totally unaware of muscle contractions. Poliovirus-induced damage to the spinal cord and brain is presented as a possible cause of AMS. The diagnosis of post-polio fatigue, evaluation AMS and management of AMS using benzodiazepines or dopamimetic agents is described. Abnormal Movements in Sleep as a Post-Polio Sequelae Despite numerous late-onset symptoms reported by polio survivors -- fatigue, muscle weakness, pain, cold intolerance, swallowing and breathing difficulties -- one symptom was totally unexpected: abnormal movements in sleep (AMS). As early as 1984 our post-polio patients were reporting muscle contractions as they fell asleep.
    [Show full text]
  • Periodic Limb Movement Disorder
    Cleveland Clinic Sleep Disorders Center 216.444.2165 Periodic Limb Movement Disorder What is periodic limb movement disorder (PLMD)? How do I know if I have PLMD? Periodic limb movement disorder (PLMD) is a condition The diagnosis is based on the clinical history as well as that was formerly called sleep myoclonus or nocturnal an overnight polysomnogram (PSG). This is a test that myoclonus. It is characterized by repetitive limb records sleep and the bioelectrical signals coming from movements that occur during sleep and cause sleep the body during sleep. Respiratory monitoring during disruption. The limb movements usually involve the the PSG allows one to rule out the presence of sleep lower extremities, consisting of extension of the big disordered breathing as a cause for the disrupted sleep toe and flexion of the ankle, the knee, and the hip. In and excessive muscle activity. Occasionally, additional some patients, the limb movements can occur in the sleep laboratory testing is useful. Blood work may be upper extremities as well. ordered to check on iron status, folic acid, vitamin B12, thyroid function, and magnesium levels. The limb movements occur most frequently in light non-REM sleep. The repetitive movements are Who gets PLMD? separated by fairly regular intervals of 5 to 90 PLMD has been less extensively studied than RLS. The seconds. There can be significant night-to-night exact prevalence is unknown. It can occur at any age; variability in the frequency of limb movements. however, the prevalence does increase with advancing What causes PLMD? age. Unlike RLS, PLMD does not appear to be related to gender.
    [Show full text]
  • Jactatio Extra-Capitis and Migraine Suppression
    J Headache Pain (2009) 10:129–131 DOI 10.1007/s10194-008-0092-0 BRIEF REPORT Jactatio extra-capitis and migraine suppression Daniel E. Jacome Received: 13 December 2008 / Accepted: 14 December 2008 / Published online: 14 January 2009 Ó Springer-Verlag 2009 Abstract Sleep often terminates migraine headaches, and the basis of psychiatric co-morbidity [1]. More specific and sleep disorders occur with greater prevalence in individuals exotic sleep headache-related syndromes have been with chronic or recurrent headaches. Rhythmic head, limb identified, such as hypnic (‘‘alarm clock’’) migraine, par- or body movements are common in children before falling oxysmal hemicrania, cluster headache and exploding head asleep, but they very rarely persist into adolescence and syndrome [2]. It is a common observation in daily practice adulthood, or appear de novo later in life as sleep-related that patients with migraines try to use the conciliation of rhythmic movement disorders. A 22-year-old female with sleep as a therapeutic strategy, even in the example of migraine without aura and history of early childhood pre- familial hemiplegic migraine, often a nocturnal or arousal dormital body rocking (jactatio) discovered that unilateral event. According to Kelman and Rains, up to 85% of slow rhythmic movements of her right foot greatly facili- migraine sufferers choose to sleep, seeking palliation from tated falling sound asleep while reclining. Sleep served headache, while 75% of the population analyzed by these every time to terminate her migraine attack. Rhythmic authors needed to sleep because of the headache [3]. The movements may serve on occasion as a therapeutic hyp- pathogenesis of sleep related headache seems to relate to notic maneuver in migraine sufferers.
    [Show full text]
  • Serotonin Syndrome: a Concise Review of a Toxic State
    IDENTIFYING AND MANAGING PSYCHIATRIC EMERGENCIES Serotonin Syndrome: A Concise Review of a Toxic State DWAYNE R. HEITMILLER, MD 33 35 EN ABSTRACT to provide a brief review of the SS in order to promote greater The serotonin syndrome is a toxic state caused by awareness, increased understanding, and more effective increased intrasynaptic serotonin and characterized by a prevention of this toxidrome. triad of altered mental status, autonomic instability and neuromuscular abnormalities. It can result from expo- PATHOPHYSIOLOGY sure to a single serotonergic agent but is more likely to Serotonin (5-hydroxytryptamine or 5-HT) is a product of be due to polypharmacy, often with drugs from multiple hydroxylation and decarboxylation of L-tryptophan.8 The classes. It develops over a short period of time and re- majority of serotonin is found in the periphery where it is solves just as quickly once identified and treated. Diag- involved in regulation of GI motility and vasomotor func- nostic criteria have been developed to assist in clinical tion. Approximately 2% of serotonin is found in the CNS practice. Treatment is largely supportive and prognosis and synthesized primarily in the raphe nucleus of the brain- is generally very favorable. Pharmacologic vigilance and stem.13 Serotonin is involved in modulating multiple CNS prevention are key. functions including core body temperature, emesis, eating behavior, analgesia, wakefulness, sexual behavior, mood, af- KEYWORDS: Serotonin syndrome, polypharmacy, 2,8,14,16 myoclonus fect, perception, and personality. The SS toxidrome is thought to result from hyperstimu- lation of postsynaptic serotonergic receptors. Clinical find- ings do not correlate with serum serotonin levels; it is the concentration at the nerve terminal that is most important.
    [Show full text]